University Of North Carolina At Chapel Hill — Chapel Hill, North Carolina

University Of North Carolina At Chapel Hill is a clinical research site located in Chapel Hill, North Carolina, United States 27599.

Crixeo Health Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.

University Of North Carolina At Chapel Hill has participated in 15 clinical trials with 1 currently active.

Therapeutic areas: Colitis, Ulcerative, Hepatitis C, Genotype 1, Crohn's Disease.

Sponsors: Bristol-Myers Squibb, Novo Nordisk A/S, Synta Pharmaceuticals Corp..

Sponsor Feasibility Report

Trust Score: 75/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University Of North Carolina At Chapel Hill?

University Of North Carolina At Chapel Hill has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University Of North Carolina At Chapel Hill conducted?

University Of North Carolina At Chapel Hill has 15 clinical trials on record, with 1 currently active. Their work covers Colitis, Ulcerative, Hepatitis C, Genotype 1, Crohn's Disease.

Is University Of North Carolina At Chapel Hill accredited by Crixeo Health?

Yes — University Of North Carolina At Chapel Hill holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about University Of North Carolina At Chapel Hill?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.